Skip to content

Article: Nicotinamide Riboside Supplementation Enhances Walking Performance in Peripheral Artery Disease: Clinical Findings

Nicotinamide Riboside Supplementation Enhances Walking Performance in Peripheral Artery Disease: Clinical Findings


Objectives

To assess the effects of NR supplementation alone and in combination with resveratrol on the six-minute walk distance in individuals with peripheral artery disease (PAD).

Journal

Nature Communications

Key Outcomes

  • NR supplementation significantly improved treadmill walking time and the six-minute walking distance (by 17.6 meters), a clinically meaningful change.
  • NR effectively improved walking performance in individuals with PAD, while resveratrol did not enhance the benefits of NR.
  • NR combined with resveratrol did not significantly improve the six-minute walk distance compared to placebo.

Duration

6 months

Dose

1000 mg*
*Patients were given NR (1000 mg) or NR (1000 mg) + Resveratrol (125 mg).

Study Design

Randomized, double-blind, placebo-controlled, phase II study in 90 peripheral artery disease (PAD) patients

Read more

Clinical

Niagen® IV (NR IV) Is Safer, Faster, and More Effective Than NAD+ IV at Raising NAD+ Levels

Objectives To assess the safety and efficacy of a single intravenous administration of NR compared to NAD+ and a saline control in terms of whole blood NAD+ changes, tolerable infusion rates, and ...

Read more
Reproductive Health

Nicotinamide Adenine Dinucleotide Precursors and Their Role in Ovarian Health: Review

SynopsisNatural NAD⁺ precursors may support ovarian health, but their tissue targets, efficiency, and side effects vary. This review outlines NAD+'s distribution inside and outside cells, its compl...

Read more